Standout Papers

Effects of Torcetrapib in Patients at High Risk for Coronary Events 2006 2026 2012 2019 2.2k
  1. Effects of Torcetrapib in Patients at High Risk for Coronary Events (2007)
    Philip J. Barter, Mark J. Caulfield et al. New England Journal of Medicine
  2. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population (2006)
    Markku S. Nieminen, D L Brutsaert et al. European Heart Journal
  3. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial (2012)
    Stefan H. Hohnloser, Ziad Hijazi et al. European Heart Journal

Immediate Impact

1 from Science/Nature 110 standout
Sub-graph 1 of 14

Citing Papers

Stroke
2024 Standout
Diagnosis and Treatment of Acute Coronary Syndromes
2022 Standout
8 intermediate papers

Works of José López‐Sendón being referenced

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes
2013
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
2009
and 5 more

Author Peers

Author Last Decade Papers Cites
José López‐Sendón 9674 3989 1192 1884 262 13.2k
Felicita Andreotti 9856 5672 1147 1832 178 14.8k
Jaap W. Deckers 7194 2866 906 969 196 10.4k
Sripal Bangalore 11226 5500 1263 2346 474 17.5k
Nicolas Danchin 10372 5193 1026 1229 568 14.8k
Marcus Flather 12950 5412 1303 869 236 16.3k
Michael E. Farkouh 6611 4715 1488 1887 337 14.6k
Karen S. Pieper 11548 3977 1243 646 246 15.0k
Mark C. Petrie 12226 4295 1044 3127 308 16.1k
Héctor Bueno 11576 3714 1361 678 384 15.3k
Deeb N. Salem 5540 3098 1404 1661 165 11.9k

All Works

Loading papers...

Rankless by CCL
2026